INOVIO BIOMEDICAL CORP (INO) is a publicly traded company in the Unknown sector. Across all available filings, 23 corporate insiders have executed 559 transactions totaling $35.3M, demonstrating a bearish sentiment with -$24.9M in net insider flow. The most recent transaction on Jun 30, 2025 involved a transaction of 2,916 shares valued at $0.
No significant insider buying has been recorded for INO in the recent period.
No significant insider selling has been recorded for INO in the recent period.
Based on recent SEC filings, insider sentiment for INO is bearish with an Insider Alignment Score of 15/100 and a net flow of -$24.9M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at INOVIO BIOMEDICAL CORP (INO) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 23 insiders are actively trading INO stock, having executed 559 transactions in the past 90 days. The most active insider is Jong Joseph Kim (Executive), who has made 102 transactions totaling $25.8M.
Get notified when executives and directors at INO file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | John Sumner Michael | Executive | Option Exercise | 2,916 | $N/A | $0 | |
| May 15, 2024 | Elizabeth Shea Jacqueline | Executive | Payment | 7,718 | $13.07 | $100.9K | |
| May 15, 2024 | Elizabeth Shea Jacqueline | Executive | Option Exercise | 17,745 | $N/A | $0 | |
| May 15, 2024 | D. Dansey Roger | Executive | Option Exercise | 2,166 | $N/A | $0 | |
| May 15, 2024 | S. Zoth Lota | Executive | Option Exercise | 2,166 | $N/A | $0 | |
| May 15, 2024 | L. Yarno Wendy | Executive | Option Exercise | 2,166 | $N/A | $0 | |
| May 15, 2024 | B. Weiner David | Executive | Option Exercise | 2,166 | $N/A | $0 | |
| May 15, 2024 | John Sumner Michael | Executive | Option Exercise | 2,386 | $N/A | $0 | |
| May 15, 2024 | Humeau Laurent | Executive | Payment | 1,703 | $13.07 | $22.3K | |
| May 15, 2024 | Humeau Laurent | Executive | Option Exercise | 4,771 | $N/A | $0 | |
| May 15, 2024 | Kies Peter | Executive | Payment | 2,562 | $13.07 | $33.5K | |
| May 15, 2024 | Kies Peter | Executive | Option Exercise | 4,771 | $N/A | $0 | |
| May 15, 2024 | Shepard Jay | Executive | Option Exercise | 2,166 | $N/A | $0 | |
| May 15, 2024 | X. Benito Simon | Executive | Option Exercise | 2,166 | $N/A | $0 | |
| May 15, 2024 | Calby Miller Ann | Executive | Option Exercise | 2,166 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 141 | $30.1M | 59.1% |
Payment(F) | 93 | $8.8M | 17.4% |
Purchase(P) | 71 | $5.2M | 10.2% |
Exercise(M) | 238 | $5.0M | 9.9% |
Exercise (Options)(X) | 1 | $1.6M | 3.1% |
Gift(G) | 10 | $159.0K | 0.3% |
Award(A) | 4 | $0 | 0.0% |
Other(J) | 1 | $0 | 0.0% |
Insider selling pressure at INOVIO BIOMEDICAL CORP has increased, with 23 insiders executing 559 transactions across all time. Total sales of $30.1M significantly outpace purchases of $5.2M, resulting in a net outflow of $24.9M. This selling activity appears largely discretionary, which may warrant closer attention from investors.